The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2023 | The future of AI in the diagnosis and management of GI cancers
Benoit Gallix, MD, PhD, American Hospital of Paris, Neuilly-sur-Seine, France, comments on the emerging role of artificial intelligence (AI) in the management of gastrointestinal cancers. Large scale data integration is necessary for AI to simultaneously analyze in vivo data such as MRI and CT scans and genomic data. By integrating multiple sets of data, a comprehensive picture of the patient’s condition can be ascertained. This interview took place at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 in Barcelona, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
